Abstract
Background: Patterns of cognitive impairment in former American football players are uncertain because objective neuropsychological data are lacking. This study characterized the neuropsychological test performance of former college and professional football players. Methods: One hundred seventy male former football players (n=111 professional, n=59 college; 45–74 years) completed a neuropsychological test battery. Raw scores were converted to T-scores using age, sex, and education-adjusted normative data. A T-score ≤ 35 defined impairment. A domain was impaired if 2+ scores fell in the impaired range except for the language and visuospatial domains due to the limited number of tests. Results: Most football players had subjective cognitive concerns. On testing, rates of impairments were greatest for memory (21.2% two tests impaired), especially for recall of unstructured (44.7%) versus structured verbal stimuli (18.8%); 51.8% had one test impaired. 7.1% evidenced impaired executive functions; however, 20.6% had impaired Trail Making Test B. 12.1% evidenced impairments in the attention, visual scanning, and psychomotor speed domain with frequent impairments on Trail Making Test A (18.8%). Other common impairments were on measures of language (i.e., Multilingual Naming Test [21.2%], Animal Fluency [17.1%]) and working memory (Number Span Backward [14.7%]). Impairments on our tasks of visuospatial functions were infrequent. Conclusions: In this sample of former football players (most of whom had subjective cognitive concerns), there were diffuse impairments on neuropsychological testing with verbal memory being the most frequently impaired domain.
Original language | English |
---|---|
Article number | 1 |
Journal | Alzheimer's Research and Therapy |
Volume | 15 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2023 |
Keywords
- Alzheimer’s disease
- American football
- Chronic traumatic encephalopathy
- Cognitive function
- Neuropsychology
- Repetitive head impacts
Fingerprint
Dive into the research topics of 'Neuropsychological test performance of former American football players'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Alzheimer's Research and Therapy, Vol. 15, No. 1, 1, 12.2023.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Neuropsychological test performance of former American football players
AU - for the DIAGNOSE CTE Research Project
AU - Alosco, Michael L.
AU - Barr, William B.
AU - Banks, Sarah J.
AU - Wethe, Jennifer V.
AU - Miller, Justin B.
AU - Pulukuri, Surya Vamsi
AU - Culhane, Julia
AU - Tripodis, Yorghos
AU - Adler, Charles H.
AU - Balcer, Laura J.
AU - Bernick, Charles
AU - Mariani, Megan L.
AU - Cantu, Robert C.
AU - Dodick, David W.
AU - McClean, Michael D.
AU - Au, Rhoda
AU - Mez, Jesse
AU - Turner, Robert W.
AU - Palmisano, Joseph N.
AU - Martin, Brett
AU - Hartlage, Kaitlin
AU - Cummings, Jeffrey L.
AU - Reiman, Eric M.
AU - Shenton, Martha E.
AU - Stern, Robert A.
AU - Su, Yi
AU - Chen, Kewei
AU - Protas, Hillary
AU - Boker, Connie
AU - Farrer, Lindsay
AU - Helm, Robert
AU - Katz, Douglas I.
AU - Kowall, Neil
AU - Mercier, Gustavo
AU - Otis, James
AU - Weller, Jason
AU - Simkin, Irene
AU - Andino, Alondra
AU - Conneely, Shannon
AU - Diamond, Courtney
AU - Fagle, Tessa
AU - Haller, Olivia
AU - Hunt, Tennyson
AU - Gullotti, Nicole
AU - Mayville, Brian
AU - McLaughlin, Kathleen
AU - Nanna, Mary
AU - Platt, Taylor
AU - Rice, Fiona
AU - Sestak, Madison
AU - Annis, Douglas
AU - Chaisson, Christine
AU - Dixon, Diane B.
AU - Finney, Carolyn
AU - Gallagher, Kerrin
AU - Lu, Jun
AU - Ojo, Emmanuel
AU - Pine, Brittany
AU - Ramachandran, Janani
AU - Bouix, Sylvain
AU - Fitzsimmons, Jennifer
AU - Lin, Alexander P.
AU - Koerte, Inga K.
AU - Pasternak, Ofer
AU - Arciniega, Hector
AU - Billah, Tashrif
AU - Bonke, Elena
AU - Breedlove, Katherine
AU - Coello, Eduardo
AU - Coleman, Michael J.
AU - Jung, Leonhard
AU - Liao, Huijun
AU - Loy, Maria
AU - Rizzoni, Elizabeth
AU - Schultz, Vivian
AU - Silva, Annelise
AU - Vessey, Brynn
AU - Wiegand, Tim L.T.
AU - Ritter, Aaron
AU - Sabbagh, Marwan
AU - de la Cruz, Raelynn
AU - Durant, Jan
AU - Golceker, Morgan
AU - Harmon, Nicolette
AU - Kaylegian, Kaeson
AU - Long, Rachelle
AU - Nance, Christin
AU - Sandoval, Priscilla
AU - Marek, Kenneth L.
AU - Serrano, Andrew
AU - Geda, Yonas
AU - Falk, Bryce
AU - Duffy, Amy
AU - Howard, Marci
AU - Montague, Michelle
AU - Osgood, Thomas
AU - Babcock, Debra
AU - Bellgowan, Patrick
AU - Goldberg, Judith
AU - Wisniewski, Thomas
AU - Kirov, Ivan
AU - Lui, Yvonne
AU - Marmar, Charles
AU - Hasanaj, Lisena
AU - Serrano, Liliana
AU - Al-Kharafi, Alhassan
AU - George, Allan
AU - Martin, Sammie
AU - Riley, Edward
AU - Runge, William
AU - Peskind, Elaine R.
AU - Colasurdo, Elizabeth
AU - Marcus, Daniel S.
AU - Gurney, Jenny
AU - Greenwald, Richard
AU - Johnson, Keith A.
N1 - Funding Information: This work was supported by grants from the National Institutes of Health (U01NS093334; P30AG072980; R01NS078337; K23NS102399; P30AG019610; K01AG054762; R01NS100952; RF1NS122854). This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1UL1TR001430. The primary funding source is the National Institute of Neurological Disorders and Stroke (NINDS), through a U01 Research Project Cooperative Agreement (U01NS093334). Funding Information: The DIAGNOSE CTE Research Project Current and Former Investigators and Key Personnel Banner Alzheimer’s Institute Investigators Eric Reiman, M.D. (Co-PI) Yi Su, Ph.D. Kewei Chen, Ph.D. Hillary Protas, Ph.D. Non-Investigators Connie Boker, M.B.A. (Director, Imaging Center Operations) Boston University School of Medicine Investigators Michael L. Alosco, Ph.D. Rhoda Au, Ph.D. Robert C. Cantu, Ph.D. Lindsay Farrer, Ph.D. Robert Helm, M.D. * Douglas I. Katz, M.D. Neil Kowall, M.D. * Jesse Mez, M.D. Gustavo Mercier, M.D., Ph.D. * James Otis, M.D. * Robert A. Stern, Ph.D. (Co-PI) Jason Weller, M.D. Non-Investigators Irene Simkin, M.S. (Lab Manager, Molecular Genetics Core Facility) Boston University Project Coordinating Center Staff Alondra Andino, B.A. (Project Administrative Manager) * Shannon Conneely, B.A. (Site Coordinator) * Courtney Diamond, M.B.A. (Project Manager) * Tessa Fagle, B.A. (Research Assistant) Olivia Haller, B.A. (Recruitment Coordinator) * Tennyson Hunt, M.B.A. (Project Administrative Manager) * Nicole Gullotti, M.B.A. (Research Administrator) * Megan Mariani, B.S., B.A. (Project Manager) Brian Mayville, B.S. (Site Coordinator) Kathleen McLaughlin, B.A. (Research Assistant) Mary Nanna, B.A. (Retention Coordinator) Taylor Platt, M.P.H. (Recruitment Coordinator) * Surya Pulukuri, B.A. (Research Assistant) Fiona Rice, M.P.H. (Project Manager) * Madison Sestak, B.S. (Assistant Recruitment Coordinator) * Boston University School of Public Health Investigators Michael McClean, Sc.D. Yorghos Tripodis, Ph.D. Data Team Staff Douglas Annis, M.S. (Systems Analyst) * Christine Chaisson, M.P.H. (Leader of Data Management Sub-team) * Diane B. Dixon (Project Manager) Carolyn Finney, B.A. (Data Manager) Kerrin Gallagher, M.P.H. (Statistical Analyst) * Kaitlin Hartlage, M.P.H. (Statistical Analyst) Jun Lu, M.S. (Data Security and Technology Analyst) Brett Martin, M.S. (Statistical Manager) Emmanuel Ojo, M.P.H. (Statistical Analyst) * Joseph N. Palmisano, M.A., M.P.H. (Leader of Data Management Sub-team) Brittany Pine, B.A., B.S. (Statistical Analyst) Janani Ramachandran, M.S. (Data Manager) Brigham and Women’s Hospital Investigators Sylvain Bouix, Ph.D. Jennifer Fitzsimmons, M.D. * Alexander P. Lin, Ph.D. Inga K. Koerte, M.D., Ph.D. Ofer Pasternak, Ph.D. Martha E. Shenton, Ph.D. (Co-PI) Non-Investigators Hector Arciniega, Ph.D. (Postdoctoral Research Fellow) Tashrif Billah, M.S. (Software Engineer) Elena Bonke, M.S. (Ph.D. Student) Katherine Breedlove, Ph.D. (Postdoctoral Research Fellow) Eduardo Coello, Ph.D. (Postdoctoral Research Fellow) Michael J. Coleman, M.A. (Senior Scientist) Leonhard Jung, (Ph.D. Student) Huijun Liao, B.S. (Study Coordinator) Maria Loy, M.B.A., M.P.H. (Senior Program Coordinator) Elizabeth Rizzoni, B.A. (Research Assistant) Vivian Schultz, M.D. (Postdoctoral Research Fellow) Annelise Silva, B.S. (Research Assistant) * Brynn Vessey, B.S. (Research Assistant) Tim L.T. Wiegand, (Ph.D. Student) Cleveland Clinic Lou Ruvo Center for Brain Health Investigators Sarah Banks, Ph.D. (Now at University of California, San Diego) Charles Bernick, M.D. (Now at University of Washington) Justin Miller, Ph.D. Aaron Ritter, M.D. Marwan Sabbagh, M.D. * Non-Investigators Raelynn de la Cruz, (Psychometrician)* Jan Durant, (Psychometrician)* Morgan Golceker (Site Coordinator) Nicolette Harmon, (Site Coordinator) * Kaeson Kaylegian, (Psychometrician)* Rachelle Long, (Site Coordinator) * Christin Nance, (Psychometrician)* Priscilla Sandoval (Site Coordinator) * George Washington University School of Medicine and Health Sciences Investigator Robert W. Turner, Ph.D. Invicro (formerly Molecular NeuroImaging) Investigator Kenneth L. Marek, M.D. Non-Investigator Andrew Serrano, M.B.A. Mayo Clinic Arizona Investigators Charles H. Adler, M.D., Ph.D., David W. Dodick, M.D. Yonas Geda, M.D., MSc (Now at Barrow Neurological Institute) Jennifer V. Wethe, Ph.D. Non-Investigators Bryce Falk, R.N. Amy Duffy, (Site Coordinator) * Marci Howard, (Psychometrician)* Michelle Montague, (Psychometrician)* Thomas Osgood, (Site Coordinator) National Institute of Neurological Disorders and Stroke (NINDS) Debra Babcock, M.D., Ph.D. (Scientific Program Official) Patrick Bellgowan, Ph.D. (Administrative Program Official)* New York University: Investigators Laura Balcer, M.D., M.S.C.E. William Barr, PhD. Judith Goldberg, Sc.D. Thomas Wisniewski, M.D. * Ivan Kirov, Ph.D. Yvonne Lui, M.D. Charles Marmar, M.D. Non-Investigators Lisena Hasanaj (Site Coordinator) Liliana Serrano Alhassan Al-Kharafi (Psychometrician)* Allan George (Psychometrician)* Sammie Martin (Psychometrician)* Edward Riley (Psychometrician)* William Runge (Psychometrician)* University of Nevada, Las Vegas Jeffrey L. Cummings, M.D., ScD (Co-PI) University of Washington and VA Puget Sound Investigator Elaine R. Peskind, M.D. Non-Investigator Elizabeth Colasurdo (Lab Manager) Washington University (CNDA) Investigators Daniel S. Marcus, Ph.D. Non-Investigator Jenny Gurney, M.S. Consultants Richard Greenwald, Ph.D. (Simbex)* Keith A. Johnson, M.D. (Massachusetts General Hospital) *No longer involved in project. Funding Information: CHA consulted for Avion, CND Life Sciences, Jazz, and Precon Health. LJB is Editor-in-Chief of the Journal of Neuro-Ophthalmology and is a paid consultant to Biogen (Cambridge, MA, USA). CB receives research support from the Ultimate Fighting Championship, Top Rank promotions, Haymon Boxing, Las Vegas Raiders, and Professional Bull Riders. He is a paid consultant for Aurora Concussion Therapy Systems, Inc. (St. Paul, MN). RA is a paid consultant to Biogen (Cambridge, MA, USA) and serves on the Scientific Advisory Board of Signant Health (Blue Bell, PA). WBB provides expert witness testimony in legal cases involving concussion and CTE. DWD reports the following conflicts: consulting: Amgen, CapiThera, Cerecin, Ceruvia Lifesciences, Cooltech, Ctrl M, Allergan, Abbvie, Biohaven, GSK, Lundbeck, Eli Lilly, Novartis, Impel, Satsuma, Theranica, WL Gore, Genentech, Nocira, Perfood, Praxis, Pfizer, AYYA Biosciences, and Revance; honoraria/expense reimbursement/royalties: American Academy of Neurology, Headache Cooperative of the Pacific, MF Med Ed Research, Biopharm Communications, CEA Group Holding Company (Clinical Education Alliance LLC), Teva (speaking), Amgen (speaking), Eli Lilly (speaking), Lundbeck (speaking), Vector psychometric Group, Clinical Care Solutions, CME Outfitters, Curry Rockefeller Group, DeepBench, Global Access Meetings, KLJ Associates, Academy for Continued Healthcare Learning, Majallin LLC, Medlogix Communications, Medica Communications LLC, MJH Lifesciences, Miller Medical Communications, Synapse, WebMD Health/Medscape, Wolters Kluwer, Oxford University Press, and Cambridge University Press; non-profit board membership: American Brain Foundation, American Migraine Foundation, ONE Neurology, Precon Health Foundation, International Headache Society Global Patient Advocacy Coalition, Atria Health Collaborative, Domestic Violence HOPE Foundation/Panfila, CSF Leak Foundation. Research Support: Department of Defense, National Institutes of Health, Henry Jackson Foundation, Sperling Foundation, American Migraine Foundation, and Patient Centered Outcomes Research Institute (PCORI); stock options/shareholder/patents/board of directors: Ctrl M (options), Aural analytics (options), ExSano (options), Palion (options), Healint (options), Theranica (options), Second Opinion/Mobile Health (options), Epien (options/board), Nocira (options), Matterhorn (shares/board), Ontologics (shares/board), King-Devick Technologies (options/board), Precon Health (options/board), AYYA Biosciences (options), Axon Therapeutics (options/board), Cephalgia Group (options/board), and Atria Health (options/salary). Patent 17189376.1-1466:vTitle: Botulinum Toxin Dosage Regimen for Chronic Migraine Prophylaxis (No fee/compensation/royalty). RCC is a Senior Advisor to the NFL Head Neck & Spine Committee; Vice President, National Operating Committee on Standards for Athletic Equipment; and Chair, Scientific Advisory Committee, Co-Founder, and Medical Director, Concussion Legacy Foundation. He is a member of the Medical Science Committee for the National Collegiate Athletic Association Student-Athlete Concussion Injury Litigation, and he receives royalties for published books from Houghton Mifflin Harcourt. JLC has provided consultation to Acadia, Alkahest, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Cassava, Cerecin, Cerevel, Cortexyme, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, Jazz, Karuna, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Samumed, Samus, Signant Health, Sunovion, Suven, United Neuroscience, and Unlearn AI pharmaceutical and assessment companies. He owns the copyright of the Neuropsychiatric Inventory. EMR is a compensated scientific advisor for Alkahest, Alzheon, Aural Analytics, Denali, Green Valley, Retromer Therapeutics, and Vaxxinity and a co-founder of ALZPath. RAS is a paid consultant to Biogen (Cambridge, MA, USA). He is a member of the Board of Directors of King-Devick Technologies, Inc. (Chicago, IL, USA), and he receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. (Lutz, FL, USA). He is a member of the Medical Science Committee for the National Collegiate Athletic Association Student-Athlete Concussion Injury Litigation. The remaining authors have no conflicts of interest to disclose. Publisher Copyright: © 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: Patterns of cognitive impairment in former American football players are uncertain because objective neuropsychological data are lacking. This study characterized the neuropsychological test performance of former college and professional football players. Methods: One hundred seventy male former football players (n=111 professional, n=59 college; 45–74 years) completed a neuropsychological test battery. Raw scores were converted to T-scores using age, sex, and education-adjusted normative data. A T-score ≤ 35 defined impairment. A domain was impaired if 2+ scores fell in the impaired range except for the language and visuospatial domains due to the limited number of tests. Results: Most football players had subjective cognitive concerns. On testing, rates of impairments were greatest for memory (21.2% two tests impaired), especially for recall of unstructured (44.7%) versus structured verbal stimuli (18.8%); 51.8% had one test impaired. 7.1% evidenced impaired executive functions; however, 20.6% had impaired Trail Making Test B. 12.1% evidenced impairments in the attention, visual scanning, and psychomotor speed domain with frequent impairments on Trail Making Test A (18.8%). Other common impairments were on measures of language (i.e., Multilingual Naming Test [21.2%], Animal Fluency [17.1%]) and working memory (Number Span Backward [14.7%]). Impairments on our tasks of visuospatial functions were infrequent. Conclusions: In this sample of former football players (most of whom had subjective cognitive concerns), there were diffuse impairments on neuropsychological testing with verbal memory being the most frequently impaired domain.
AB - Background: Patterns of cognitive impairment in former American football players are uncertain because objective neuropsychological data are lacking. This study characterized the neuropsychological test performance of former college and professional football players. Methods: One hundred seventy male former football players (n=111 professional, n=59 college; 45–74 years) completed a neuropsychological test battery. Raw scores were converted to T-scores using age, sex, and education-adjusted normative data. A T-score ≤ 35 defined impairment. A domain was impaired if 2+ scores fell in the impaired range except for the language and visuospatial domains due to the limited number of tests. Results: Most football players had subjective cognitive concerns. On testing, rates of impairments were greatest for memory (21.2% two tests impaired), especially for recall of unstructured (44.7%) versus structured verbal stimuli (18.8%); 51.8% had one test impaired. 7.1% evidenced impaired executive functions; however, 20.6% had impaired Trail Making Test B. 12.1% evidenced impairments in the attention, visual scanning, and psychomotor speed domain with frequent impairments on Trail Making Test A (18.8%). Other common impairments were on measures of language (i.e., Multilingual Naming Test [21.2%], Animal Fluency [17.1%]) and working memory (Number Span Backward [14.7%]). Impairments on our tasks of visuospatial functions were infrequent. Conclusions: In this sample of former football players (most of whom had subjective cognitive concerns), there were diffuse impairments on neuropsychological testing with verbal memory being the most frequently impaired domain.
KW - Alzheimer’s disease
KW - American football
KW - Chronic traumatic encephalopathy
KW - Cognitive function
KW - Neuropsychology
KW - Repetitive head impacts
UR - http://www.scopus.com/inward/record.url?scp=85145428760&partnerID=8YFLogxK
U2 - 10.1186/s13195-022-01147-9
DO - 10.1186/s13195-022-01147-9
M3 - Article
C2 - 36597138
AN - SCOPUS:85145428760
SN - 1758-9193
VL - 15
JO - Alzheimer's Research and Therapy
JF - Alzheimer's Research and Therapy
IS - 1
M1 - 1
ER -